Significant Ownership of Advent Life Sciences LLP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Advent Life Sciences LLP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/Rajesh Parekh, Ph.D. - General Partner of Advent Life Sciences LLP
- Manager location
- London, United Kingdom
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Advent Life Sciences LLP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Advent Life Sciences LLP
Significant Ownership of Advent Life Sciences LLP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | Common Stock, par value $0.00001 per share | 3.3% | $11,768,148 | 2,071,857 | Rajesh Parekh, Ph.D. | 13 Feb 2026 | ||
| AFIB | Acutus Medical, Inc. | Common Stock, par value $0.001 per share | 0% | $0 | 0 | Advent Life Sciences LLP | 09 Jul 2025 |
Schedules 13D/G Reported by Advent Life Sciences LLP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.